Share-based Payment Arrangement, Expense of Zomedica Corp. from 31 Dec 2016 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Zomedica Corp. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2016 to 30 Sep 2024.
  • Zomedica Corp. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $473,000, a 72% decline year-over-year.
  • Zomedica Corp. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $3,538,000, a 46% decline year-over-year.
  • Zomedica Corp. annual Share-based Payment Arrangement, Expense for 2023 was $6,263,000, a 21% decline from 2022.
  • Zomedica Corp. annual Share-based Payment Arrangement, Expense for 2022 was $7,891,000, a 11% increase from 2021.
  • Zomedica Corp. annual Share-based Payment Arrangement, Expense for 2021 was $7,092,000, a 328% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Zomedica Corp. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $3,538,000 $473,000 -$1,195,000 -72% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $4,733,000 $859,000 -$866,000 -50% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $5,599,000 $1,101,000 -$664,000 -38% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $6,263,000 $1,105,000 -$333,000 -23% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
Q3 2023 $6,596,000 $1,668,000 -$252,000 -13% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $6,848,000 $1,725,000 -$767,000 -31% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $7,615,000 $1,765,000 -$276,000 -14% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $7,891,000 $1,438,000 -$1,151,000 -44% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $9,042,000 $1,920,000 +$482,000 +34% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $8,560,000 $2,492,000 +$710,000 +40% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $7,850,000 $2,041,000 +$758,000 +59% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $7,092,000 $2,589,000 +$1,411,651 +120% 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $5,680,349 $1,438,000 +$1,250,031 +665% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $4,430,318 $1,782,000 +$1,646,156 +1212% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $2,784,162 $1,283,000 +$1,127,978 +728% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $1,656,184 $1,177,349 +$1,177,349 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022 2022 FY
Q3 2020 $478,835 $187,969 -$10,019 -5.1% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $488,854 $135,844 +$135,844 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $353,010 $155,022 -$2,186,082 -93% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q4 2019 $2,539,092 $0 $0 01 Oct 2019 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $2,539,092 $197,988 +$197,988 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $2,341,104 $0 -$1,597 01 Apr 2019 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $2,342,701 $2,341,104 +$2,335,413 +41037% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $7,288 $0 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 $0 -$675,941 -100% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $1,597* +$1,597 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $5,691 01 Jan 2018 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q3 2017 $675,941 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $0 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2

Zomedica Corp. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $6,263,000 -$1,628,000 -21% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
2022 $7,891,000 +$799,000 +11% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $7,092,000 +$5,435,816 +328% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $1,656,184 -$882,908 -35% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2022 FY
2019 $2,539,092 +$2,531,804 +34739% 01 Jan 2019 31 Dec 2019 10-K 26 Feb 2021 2020 FY
2018 $7,288 -$842,391 -99% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2020 2019 FY
2017 $849,679 -$618,255 -42% 01 Jan 2017 31 Dec 2017 10-K/A 14 Mar 2019 2018 FY
2016 $1,467,934 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.